Specialized 3-D MRI scans to precisely measure living and dying tumor tissue to quickly show whether highly toxic chemotherapy – delivered directly through a tumor’s blood supply – is working, demonstrates a series of studies involving 140 American men and women with liver tumors. The findings are the first “proof of principle” that this technology can show tumors in three dimensions and accurately measure tumor viability and death, the researchers report.